Contact Us
Drug Search Results
More Filters [+]

ENDO-PAT2000

Alternative Names: endo-pat2000, endopat2000, endo pat2000, endopat-2000, endopat 2000
Latest Update: 2024-05-01
Latest Update Note: PubMed Publication

Product Description

Endothelial function was evaluated by peripheral artery tonometry using Endo-PAT 2000 (Itamar Medical) (Sourced from: https://pubmed.ncbi.nlm.nih.gov/23209885/)

Mechanisms of Action: Device

Novel Mechanism: No

Modality: Device

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sloan Kettering Medical Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ENDO-PAT2000

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Prostatic Diseases|Prostate Cancer

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
0102-15-RMC

P4

Completed

Prostatic Diseases|Prostate Cancer

2018-07-01

NCT01500902

N/A

Completed

Acute Coronary Syndrome

2015-03-01

CLINEX 02

N/A

Completed

Hypertension|Sleep Apnea, Obstructive

2013-01-01

Recent News Events

Date

Type

Title

05/01/2024

PubMed

 Endothelial dysfunction in breast cancer survivors on aromatase inhibitors: changes over time.

02/01/2024

PubMed

 A nutraceutical with Citrus bergamia and Cynara cardunculus improves endothelial function in adults with non-alcoholic fatty liver disease.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions